We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
-2.87%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.4B
AUM Growth
-$4.5B
(-6.3%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,643
New
69
Increased
632
Reduced
516
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$156M |
| 2 |
Amazon
AMZN
|
+$104M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$79.1M |
| 4 |
Eversource Energy
ES
|
+$73.2M |
| 5 |
Exelon
EXC
|
+$67.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$159M |
| 2 |
Meta Platforms (Facebook)
META
|
+$120M |
| 3 |
Avantor
AVTR
|
+$108M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$99.1M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.43% |
| 2 | Healthcare | 16.31% |
| 3 | Industrials | 15.57% |
| 4 | Utilities | 11.18% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
501
Bank of New York Mellon
BNY
$110B
| $14M | 0.02% |
364,504
-4,143
| -1% | -$177K |
|
502
Nurix Therapeutics
NRIX
$2.79B
| $14M | 0.02% |
1,076,349
-354,016
| -25% | -$5.6M |
|
503
Veeva Systems
VEEV
$39.2B
| $14M | 0.02% |
84,850
+5,529
| +7% | +$1.1M |
|
504
Annexon
ANNX
$868M
| $14M | 0.02% |
2,258,711
+29,656
| +1% | +$160K |
|
505
Tyson Foods
TSN
$19.9B
| $13.9M | 0.02% |
211,461
-15,924
| -7% | -$1.26M |
|
506
Shopify
SHOP
$200B
| $13.8M | 0.02% |
511,388
-845,832
| -62% | -$28.8M |
|
507
Keysight
KEYS
$60.7B
| $13.6M | 0.02% |
86,331
-1,936
| -2% | -$310K |
|
508
Parker-Hannifin
PH
$134B
| $13.6M | 0.02% |
56,052
+43
| +0.1% | +$11.6K |
|
509
PACCAR
PCAR
$68.7B
| $13.5M | 0.02% |
242,190
+5,244
| +2% | +$305K |
|
|
HES
510
DELISTED
Hess
HES
| $13.5M | 0.02% |
123,960
-384
| -0.3% | -$42.6K |
|
511
BP
BP
$110B
| $13.4M | 0.02% |
470,336
+242,411
| +106% | +$7.21M |
|
|
KDNY
512
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.4M | 0.02% |
+682,112
| New | +$13.7M |
|
513
Canadian Imperial Bank of Commerce
CM
$112B
| $13.4M | 0.02% |
304,132
+8,598
| +3% | +$419K |
|
514
Hershey
HSY
$37.3B
| $13.4M | 0.02% |
60,682
+379
| +0.6% | +$84.9K |
|
515
Bentley Systems
BSY
$10.6B
| $13.4M | 0.02% |
436,524
+35,008
| +9% | +$1.28M |
|
516
Mid-America Apartment Communities
MAA
$15.6B
| $13.3M | 0.02% |
86,084
-9,017
| -9% | -$1.55M |
|
517
Dow Inc
DOW
$21.9B
| $13.3M | 0.02% |
303,162
-1,340
| -0.4% | -$67.9K |
|
518
M&T Bank
MTB
$36.8B
| $13.3M | 0.02% |
75,249
+752
| +1% | +$133K |
|
519
Ameriprise Financial
AMP
$50B
| $13.3M | 0.02% |
52,603
-486
| -0.9% | -$128K |
|
520
Cameco
CCJ
$42.8B
| $13.2M | 0.02% |
495,632
+79,892
| +19% | +$2.04M |
|
|
EXE
521
Expand Energy Corp
EXE
$21.8B
| $13M | 0.02% |
138,012
-172,974
| -56% | -$16.3M |
|
522
Rockwell Automation
ROK
$49.7B
| $13M | 0.02% |
60,282
-893
| -1% | -$208K |
|
523
Snowflake
SNOW
$117B
| $12.9M | 0.02% |
75,922
+6,682
| +10% | +$1.11M |
|
524
Li Auto
LI
$12B
| $12.6M | 0.02% |
549,043
+1,500
| +0.3% | +$46.7K |
|
525
Baxter International
BAX
$14B
| $12.6M | 0.02% |
234,076
-3,702
| -2% | -$223K |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q3 2022 Portfolio in Review
As of Q3 2022, Pictet Asset Management (Switzerland) held 1,643 positions worth $67.4B, down 6.3% from $71.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pictet Asset Management (Switzerland)'s Q3 2022 filing shows 69 new, 632 increased, 516 reduced and 78 closed positions. Its largest new stake was Ventyx Biosciences: 1,071,983 shares worth $37.4M. The largest sale was ZENDESK INC, an estimated $159M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q3 2022 buy was Ventyx Biosciences: 1,071,983 shares worth $37.4M.
- Pictet Asset Management (Switzerland) added most to Weyerhaeuser in Q3 2022, an estimated $156M increase.
- Pictet Asset Management (Switzerland)'s biggest Q3 2022 reduction was ZENDESK INC, cutting an estimated $159M.
- Pictet Asset Management (Switzerland) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $32M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 15% of its $67.4B portfolio in Q3 2022.
- Pictet Asset Management (Switzerland) opened 69 new positions and closed 78 in Q3 2022.
- Pictet Asset Management (Switzerland)'s portfolio value fell 6.3% quarter-over-quarter to $67.4B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.